Daniel J. DiStefano

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection

Amy S. Espeseth, Pedro J. Cejas, Michael Citron et al. · npj Vaccines · 2020 · 178 citations · Full text

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein

Aimin Tang, Zhifeng Chen, Kara S. Cox et al. · Nature Communications · 2019 · 142 citations · Full text

<i>In Vitro</i>Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

Ming‐Tain Lai, Meizhen Feng, Jean‐Pierre Falgueyret et al. · Antimicrobial Agents and Chemotherapy · 2013 · 140 citations · Full text

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

Sita Awasthi, John M. Lubinski, Carolyn E. Shaw et al. · Journal of Virology · 2011 · 81 citations · Full text

Veterinary Vaccine, Hsv-2 Dna, Immunology +20

Novel Rotavirus VP7 Typing Assay Using a One-Step Reverse Transcriptase PCR Protocol and Product Sequencing and Utility of the Assay for Epidemiological Studies and Strain Characterization, Including Serotype Subgroup Analysis

Daniel J. DiStefano, Nikolai Kraiouchkine, Laura Mallette et al. · Journal of Clinical Microbiology · 2005 · 73 citations · Full text